Artificial intelligence in pathology: a framework for preserving brain capital in the diagnostic apex

Clinical Snapshot

Key Findings

• Effect Size: Not applicable - conceptual framework

• Primary Outcome: Five-criterion framework: Contextual Literacy, Responsibility, Evidence Gap Analysis, Verification, and Opportunity Cost

• Nnt Or Sensitivity: Framework identifies successful tools (Ki-67 quantification, breast cancer screening) versus cognitively burdensome tools

• Confidence Interval: Not provided

Clinical Application

High feasibility as evaluation framework, though implementation would require institutional commitment and training Relevant to Australian pathology services under NPAAC accreditation, particularly as TGA develops AI medical device regulations and RCPA considers AI integration guidelines Pathology departments considering AI implementation, particularly in Australia where TGA regulation of AI medical devices is evolving

Abstract

AIM: To present a five-criterion calibration framework for evaluating artificial intelligence (AI) tools in pathology centered on preserving "brain capital" - the finite cognitive resources available to clinicians - and stabilizing the "diagnostic apex," the point where histological evidence meets clinical judgment. METHODS: Using cognitive load theory (CLT) and implementation science, we developed the Pathology AI Diagnostic Balance - a conceptual model mapping the physician-specimen interaction within working memory and IT infrastructure constraints - and examined it in the context of peer-reviewed case studies of implemented pathology AI tools. RESULTS: The framework identifies five criteria: Contextual Literacy (integration of clinical history), Responsibility (preservation of signing authority), Evidence Gap Analysis (closure of diagnostic uncertainty), Verification (feasibility of quality control), and Opportunity Cost (return on cognitive investment). Successful tools, such as Ki-67 quantification and breast cancer screening, reduce cognitive burden by automating routine tasks or enabling rapid verification. Conversely, tools requiring an exhaustive re-review or producing opaque recommendations deplete cognitive bandwidth, causing decision fatigue and diagnostic errors. CONCLUSION: Pathologists are positioned to exercise evaluative authority over tools that increase extraneous cognitive load. Clinical expertise represents pathologists' most distinctive contribution to AI development: defining which failure modes matter clinically, what context an AI must integrate, and whether a tool serves patient care. By prioritizing cognitive sustainability over purely technical metrics, the profession can ensure AI functions as a genuine enhancement of diagnostic capability rather than an additional burden on diagnostic workflows.